TY - CHAP M1 - Book, Section TI - Skin Cancer in Transplant Patients A1 - Labib, Angelina A1 - Rajabi-Estarabadi, Ali A1 - Nouri, Keyvan A2 - Nouri, Keyvan PY - 2023 T2 - Skin Cancer: A Comprehensive Guide AB - SUMMARYAs the number of transplant recipients increases, the incidence of squamous cell carcinoma (SCC), basal cell carcinoma (BCC), melanoma, Kaposi sarcoma, and Merkel cell carcinoma (MCC) increases.SCC causes more morbidity and mortality in transplant recipients.Many factors play a role in the development and nature of SCC, including sun exposure, infection with human papillomavirus (HPV), and immunosuppressive drugs.Exploration of antirejection drugs has revealed both direct and indirect carcinogenesis mechanisms in transplant recipients.There are many ways to treat SCC and other skin lesions in transplant patients, including excision, destruction, Mohs surgery, oral retinoids, and reduction of immune system suppressants.There is an increased risk of reoccurrence and metastasis in this subset of patients, requiring increased medical attention. SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/03/28 UR - dermatology.mhmedical.com/content.aspx?aid=1194726163 ER -